share_log

招商信诺人寿出席第四次涉外与特需医疗服务学术会议

China Merchants Cigna Corp Life Insurance attended the fourth academic Conference on Foreign-related and Special Medical Services

證券時報 ·  Nov 2, 2021 22:30
A few days ago, the fourth academic Conference on Foreign-related and Special Medical Services and the Fifth Foreign-related High-end Medical Summit Forum of Guangdong Province was successfully held in Guangzhou. The meeting was sponsored by the Guangdong Medical Association, hosted by the Foreign-related and Special needs Medical Service Branch of the Guangdong Medical Association, and co-sponsored by the Southern Hospital of Southern Medical University. it gathered more than 300 heavyweight guests from the National Health Commission, the State Drug Administration, the Guangdong Health Commission and the Medical Association, as well as directors and experts from well-known medical institutions at home and abroad. China Merchants Cigna Corp Life Insurance Co., Ltd. (hereinafter referred to as "China Merchants Cigna Corp Life Insurance"), as the only high-end medical insurance institution invited to speak, attended the meeting, delivered a keynote speech and participated in the round table discussion. As an annual academic event in the high-end medical field, the purpose of the conference is to discuss the development strategy of foreign-related and special medical services, and to standardize international medical management standards and realize the organic integration of general medicine and international medicine. further promote the integration of medical institutions and commercial insurance and other issues conducted in-depth discussion and exchange. At the meeting, Ms. Xu Jing, President of China Merchants Cigna Corp Life Health Insurance and General Manager of Health Management Company, had a wonderful sharing on the theme of "innovative integration of high-end medical insurance". Ms. Xu Jing first introduced the overseas mature experience of managed medical and health services of Cigna Corp Group, and also shared the leading practice of Cigna Corp Life Insurance in the integrated development of "health insurance and health management". Xu Jing mentioned: "on the one hand, China Merchants Cigna Corp Life Insurance has more than 800 direct payment medical institutions in China and as many as 1.5 million cooperative medical institutions around the world, bringing together a global medical network to help customers enjoy local high-quality medical resources all over the world. On the other hand, with the help of its wholly-owned health management subsidiary, through professional "managed" high-end medical insurance products, Cigna Corp Life Insurance not only provides customers with high annual insurance and wide coverage, but also actively embeds health management services and provides full-process health management services that integrate prevention, treatment and rehabilitation. At present, China Merchants Cigna Corp Life Insurance has provided high-end medical insurance services to more than 35% of the world's top 500 enterprises. During the round-table discussion on "Diversified Services in Foreign-related and Special needs Medical Services", Ms. Xu Jing exchanged and shared with four experts from the Southern Hospital of Southern Medical University and the second people's Hospital of Guangdong Province. Ms. Xu Jing said that in the future, Cigna Corp Life Insurance will continue to explore the integrated development of insurance industry and medical and health industry, and build a "health insurance + health management" ecosystem. To provide more customers with high-value health insurance and health services. Ms. Xu Jing, President of China Merchants Cigna Corp Life Health Insurance and General Manager of Health Management Company, attended the meeting and delivered a keynote speech. Ms. Xu Jing, President of China Merchants Cigna Corp Life Health Insurance and General Manager of Health Management Company, participated in the round table discussion (CIS).
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment